Stay up-to-date on the latest industry, member, and policy related news.
MichBio members can submit news to be shared here, on our social media, and in our monthly newsletter.
ANN ARBOR, Mich., September 13, 2024 – ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today announced that it has secured $65M in Series D financing. Johnson & Johnson Innovation – JJDC, Inc. led the round that was backed by a consortium of investors that included…
The Centers for Medicare & Medicaid Services (CMS) finalized a new Transitional Coverage for Emerging Technologies (TCET) Pathway to expedite Medicare coverage of some FDA-approved breakthrough products. Under this finalized pathway, eligible US Food and Drug Administration (FDA) designated breakthrough devices that fall within a Medicare benefit category can obtain national coverage for several years…
The Centers for Medicare & Medicaid Services (CMS) announced recently the prices that they have set for the first 10 medications as an outcome of the Inflation Reduction Act’s drug provisions. For the first time, the law provides Medicare the ability to directly “negotiate” (in effect, set, as otherwise significant penalties are imposed) the prices…
The Federal Trade Commission (FTC) held a virtual open meeting on the heels of issuing its Interim Report on Pharmacy Benefit Managers (PBMs). A press release summarized the report’s findings. Members of the public and other stakeholders provided arguments for PBM reform at the virtual meeting, citing the many ramifications that PBM business practices have had on patient…
On January 22nd, 2007, Pfizer Global Research and Development in Ann Arbor closed its doors, resulting in thousands of job losses. Just two days later, Dan Ross established TransPharm Preclinical Solutions. Ross’s motivations for starting the company were numerous, with the loss of his beloved job being a significant factor. Determined to continue working in…
A new $60 million Michigan Innovation Fund to help launch Michigan-based startups got the support of the Michigan legislature last month, as it was included in the $82.5 billion state budget lawmakers passed for the 2025 fiscal year. While the $60 million met most lawmakers’ expectations, three House representatives are sponsoring a pending bill package that would…
MichBio was honored to be part of Team Michigan at the SelectUSA Investment Summit, the highest profile event in the United States to facilitate business investment by connecting thousands of investors, companies, economic development organizations (EDOs), and industry experts to make deals happen. Hosted by the U.S. Department of Commerce, the Investment Summit is a one-stop shop for…
The US Patent & Trademark Office (USPTO) has issued a Notice of Proposed Rulemaking (NPRM) regarding Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting. The intent is to make it cheaper and easier to strike down whole families of patents to prevent them “from potentially deterring competition.” “BIO [Biotechnology Innovation Organization] believes that the proposed…
Stephen Rapundalo, PhD, MichBio President and CEO and Emily Brockman, Director, Member Relations, joined the Michigan Economic Development Corporation (MEDC) in hosting the State of Michigan Pavilion at this year’s BIO International Convention, the largest global event for the biosciences industry. The 2024 event witnessed 19,500 industry leaders attending from 70 countries, and a record…
LIVONIA, MI (July 7, 2024) – Registration is now open for the new one-day Surface Metrology and Tribology class which will be held in Livonia, Michigan, Nov. 14, 2024. The 1-day class offers a unique opportunity to learn the fundamentals of surface roughness, friction, and wear analysis, and their applications in manufacturing and product development.…
SAN DIEGO (June 17, 2024) – TrialAssure, a leading provider of pharmaceutical technology advancing clinical trial disclosure, data sharing, and transparency, announced today the release of TrialAssure LINK® AI 2.0. This new version is updated and designed to assist pharmaceutical, biotechnology companies, clinical research organizations, and other service providers in creating drafts of common regulatory…
ANN ARBOR, MI, JUNE 5, 2024—Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com. PCRassays.com offers more than 200 qPCR-based assays for infectious diseases, over 50 of which are multiplex assays, including panels for wound, upper respiratory, urinary tract,…
Stryker (NYSE: SYK), a global medical technology leader, has signed an agreement to acquire Artelon, a company specializing in soft tissue fixation products for foot and ankle and sports medicine procedures. This acquisition aims to bolster Stryker’s capabilities in ligament and tendon reconstruction. Artelon’s synthetic technology enhances biological and mechanical reconstruction, with over 60,000 implantations…
MichBio, the association for Michigan’s biosciences industry, announced during the 2024 Mackinac Policy Conference that it is launching a statewide effort to update the Michigan Bio-Industry Roadmap for Success. The Roadmap is a strategic plan released in early 2016 for growing Michigan’s biosciences industry into a global leader. “Michigan’s bio-industry is at a critical point…
By Melvin J. Muskovitz, Esq. The U. S. Department of Labor (DOL) has issued a new rule addressing worker classification under the Fair Labor Standards Act (FLSA). While the rule, which went into effect on March 11, 2024, has some aspects that favor employers, it is intended to narrow the scope of workers deemed to…